249 related articles for article (PubMed ID: 37599803)
1. Perspective vaccines for emerging viral diseases in farm animals.
Allam AM; Elbayoumy MK; Ghazy AA
Clin Exp Vaccine Res; 2023 Jul; 12(3):179-192. PubMed ID: 37599803
[TBL] [Abstract][Full Text] [Related]
2. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities.
Ghattas M; Dwivedi G; Lavertu M; Alameh MG
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960236
[TBL] [Abstract][Full Text] [Related]
3. Quantum vaccinomics platforms to advance in vaccinology.
de la Fuente J; Contreras M
Front Immunol; 2023; 14():1172734. PubMed ID: 37398646
[TBL] [Abstract][Full Text] [Related]
4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
5. Virus-Like Particle Vaccines Against Respiratory Viruses and Protozoan Parasites.
Chu KB; Quan FS
Curr Top Microbiol Immunol; 2021; 433():77-106. PubMed ID: 33650036
[TBL] [Abstract][Full Text] [Related]
6. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology.
Bello MB; Yusoff K; Ideris A; Hair-Bejo M; Jibril AH; Peeters BPH; Omar AR
Viruses; 2020 Apr; 12(4):. PubMed ID: 32316317
[TBL] [Abstract][Full Text] [Related]
8. Virus-like particle vaccinology, from bench to bedside.
Mohsen MO; Bachmann MF
Cell Mol Immunol; 2022 Sep; 19(9):993-1011. PubMed ID: 35962190
[TBL] [Abstract][Full Text] [Related]
9. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.
Poland GA; Ovsyannikova IG; Kennedy RB; Haralambieva IH; Jacobson RM
OMICS; 2011 Sep; 15(9):625-36. PubMed ID: 21732819
[TBL] [Abstract][Full Text] [Related]
10. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
[TBL] [Abstract][Full Text] [Related]
11. Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.
Rodrigues AF; Soares HR; Guerreiro MR; Alves PM; Coroadinha AS
Biotechnol J; 2015 Sep; 10(9):1329-44. PubMed ID: 26212697
[TBL] [Abstract][Full Text] [Related]
12. Recent Development of Ruminant Vaccine Against Viral Diseases.
Choudhury SM; Ma X; Dang W; Li Y; Zheng H
Front Vet Sci; 2021; 8():697194. PubMed ID: 34805327
[TBL] [Abstract][Full Text] [Related]
13. Virus like particle-based vaccines against emerging infectious disease viruses.
Liu J; Dai S; Wang M; Hu Z; Wang H; Deng F
Virol Sin; 2016 Aug; 31(4):279-87. PubMed ID: 27405928
[TBL] [Abstract][Full Text] [Related]
14. Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
Ramezanpour B; Haan I; Osterhaus A; Claassen E
Vaccine; 2016 Dec; 34(50):6436-6448. PubMed ID: 28029542
[TBL] [Abstract][Full Text] [Related]
15. New viral vectors for infectious diseases and cancer.
Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
[TBL] [Abstract][Full Text] [Related]
16. Current status and future directions of fish vaccines employing virus-like particles.
Jeong KH; Kim HJ; Kim HJ
Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976
[TBL] [Abstract][Full Text] [Related]
17. Modern vaccine strategies for emerging zoonotic viruses.
Ahmed A; Safdar M; Sardar S; Yousaf S; Farooq F; Raza A; Shahid M; Malik K; Afzal S
Expert Rev Vaccines; 2022 Dec; 21(12):1711-1725. PubMed ID: 36384000
[TBL] [Abstract][Full Text] [Related]
18. Vaccinomics: a future avenue for vaccine development against emerging pathogens.
de la Fuente J; Contreras M
Expert Rev Vaccines; 2021 Dec; 20(12):1561-1569. PubMed ID: 34582295
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
